JP2023539370A5 - - Google Patents
Info
- Publication number
- JP2023539370A5 JP2023539370A5 JP2023514418A JP2023514418A JP2023539370A5 JP 2023539370 A5 JP2023539370 A5 JP 2023539370A5 JP 2023514418 A JP2023514418 A JP 2023514418A JP 2023514418 A JP2023514418 A JP 2023514418A JP 2023539370 A5 JP2023539370 A5 JP 2023539370A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063073910P | 2020-09-02 | 2020-09-02 | |
| US63/073,910 | 2020-09-02 | ||
| US202163147473P | 2021-02-09 | 2021-02-09 | |
| US63/147,473 | 2021-02-09 | ||
| PCT/US2021/048771 WO2022051437A2 (en) | 2020-09-02 | 2021-09-01 | Methods to stimulate hla-agnostic immune responses to proteins using nucleated cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023539370A JP2023539370A (ja) | 2023-09-13 |
| JPWO2022051437A5 JPWO2022051437A5 (https=) | 2024-09-10 |
| JP2023539370A5 true JP2023539370A5 (https=) | 2024-09-10 |
Family
ID=78212608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023514418A Pending JP2023539370A (ja) | 2020-09-02 | 2021-09-01 | 有核細胞を使用してタンパク質に対するｈｌａ非依存的な免疫応答を刺激する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230263879A1 (https=) |
| EP (1) | EP4208192A2 (https=) |
| JP (1) | JP2023539370A (https=) |
| KR (1) | KR20230079066A (https=) |
| CN (1) | CN116406283A (https=) |
| TW (1) | TW202227125A (https=) |
| WO (1) | WO2022051437A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202241466A (zh) * | 2020-12-29 | 2022-11-01 | 美商Ｓｑｚ生物科技公司 | 以經修飾ｐｂｍｃ治療癌症之方法 |
| JP2024536840A (ja) * | 2021-09-26 | 2024-10-08 | ウーシー バイオロジクス アイルランド リミテッド | Ｉｌ－２バリアント及びその融合タンパク質 |
| WO2025140126A1 (en) * | 2023-12-25 | 2025-07-03 | Everest Medicines (China) Co., Ltd. | Therapeutic ly6k mrna vaccine for cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7523203B2 (ja) * | 2014-10-31 | 2024-07-26 | マサチューセッツ インスティテュート オブ テクノロジー | 生体分子の免疫細胞への送達 |
| US12599656B2 (en) * | 2018-03-12 | 2026-04-14 | Stemcell Technologies Canada Inc. | Methods for treating HPV-associated diseases |
| MX2021006393A (es) * | 2018-11-29 | 2021-10-13 | Univ Texas | Metodos para expansion ex vivo de celulas exterminadoras naturales y uso de las mismas. |
| CA3131701A1 (en) * | 2019-02-28 | 2020-09-03 | Sqz Biotechnologies Company | Delivery of biomolecules to pbmcs to modify an immune response |
| JP7820663B1 (ja) * | 2024-09-25 | 2026-02-26 | ダイキン工業株式会社 | 設備管理装置、プログラム、設備管理システム |
-
2021
- 2021-09-01 KR KR1020237010604A patent/KR20230079066A/ko active Pending
- 2021-09-01 WO PCT/US2021/048771 patent/WO2022051437A2/en not_active Ceased
- 2021-09-01 US US18/043,613 patent/US20230263879A1/en active Pending
- 2021-09-01 JP JP2023514418A patent/JP2023539370A/ja active Pending
- 2021-09-01 CN CN202180071943.1A patent/CN116406283A/zh active Pending
- 2021-09-01 EP EP21794031.1A patent/EP4208192A2/en active Pending
- 2021-09-02 TW TW110132703A patent/TW202227125A/zh unknown